| Ticker: | JFVAX |
| Manager: | Walter T. McCormick |
| Manager Since: | 06/11 |
| NAV (05/21/2013): | 13.06 |
| Objective: | Equity - Growth |
| Peer: | GR LV |
| Net Assets ($mil): | 7.84 |
| Inception: | 05/31/2011 |
JFVAX : Description
The fund was incepted in November 2000 and is managed by John Hancock Advisors, LLC. The fund seeks long-term capital appreciation. The fund invests at least 80% of its assets in equity securities of U.S. and foreign companies. Under normal market conditions, the fund invests primarily in medium-capitalization companies. The fund may invest more than 5% of its assets in securities of individual companies. The fund distributes its dividends and capital gains, if any, annually.
JFVAX : Composition - 05/13
| Stocks | 98.94% |
| Foreign Stocks | 9.76% |
| Cash | 1.29% |
| Bonds | 0.00% |
| Foreign Bonds | 0.00% |
| Preferred | 0.00% |
| Convertible | 0.00% |
| Other | -0.23% |
| Foreign Hedged | 0.00% |
JFVAX : Style Analysis - 05/13
| Large Growth | 0.00% |
| Large Value | 87.01% |
| Small Growth | 0.00% |
| Small Value | 0.00% |
| Foreign Stock | 0.00% |
| Emerging Market | 0.00% |
| Precious Metals | 0.00% |
| Intermediate Bond | 0.00% |
| High Yield Bond | 0.00% |
| Foreign Bond | 0.00% |
JFVAX : Risk Analysis
| Beta v. S&P 500 | NA |
| Beta v. EAFE | NA |
| Beta v. Barclays Agg Bond | NA |
| Alpha 3 Yr | NA |
| Alpha 5 Yr | NA |
| R-Sq 3 Yr | NA |
| R-Sq 5 Yr | NA |
| Std Dev 3 Yr | NA |
| Std Dev 5 Yr | NA |
| Sharpe 3 Yr | NA |
| Sharpe 5 Yr | NA |
JFVAX : Fees
| Expense Ratio | 1.74 |
| % Max Load | 5.00 |
| % Min Load | 0.00 |
| % Deferred Load | NA |
| % Redemption | NA |
| % Max 12 B1 Fee | 0.30 |
| % Max Mgt Fee | 0.67 |
JFVAX : Purchase Choices:
| Min Initial Investment | 2500 |
| Min Subsequent Investment | 0 |
JFVAX : Returns Analysis - Annual
| 2012 | YTD | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NAV ($) | 9.37 | 13.06 | |||||||||
| Total Return (%) | 23.02 | 12.15 | |||||||||
| Annual Dividend Yield (%) | 0.81 | 0.73 | |||||||||
| Relative Performance | |||||||||||
| Rel Performance-S&P500(%) | 70.34 | -5.87 | |||||||||
| Rel Performance-Obj.Ret.(%) | 87.51 | 12.12 | |||||||||
| Ret.Quintile vs Obj(1 is best) | 1 | 3 | |||||||||
| Turnover, Yields, and Gains | |||||||||||
| Fund Assets Net($mil) | 4 | 8 | |||||||||
| Annual Turnover (%) | 26.00 | 40.00 | |||||||||
| Annual Dividend Paid ($) | 0.09 | 0.00 | |||||||||
| Annual Capital Gains Paid($) | 0.49 | 0.00 | |||||||||
JFVAX : Returns Analysis - Trailing Total Return
| 1 Month | 3 Month | 6 Month | YTD | 1 Year | 3 Year | 5 Year | 10 Year | 15 Year | 20 Year | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Return (through 05/13) | 1.74% | 4.78% | 16.37% | 12.15% | 21.97% | NA | NA | NA | NA | NA |
| Ret. Percentile vs. Obj. (1 is best) | 28 | 68 | 21 | 42 | 3 | NA | NA | NA | NA | NA |
JFVAX : Stock Portfolio Snapshot - 05/13
| Average Price/Earnings | 22.03 |
| Average Price/Book | 3.97 |
| Average EPS Growth | 13.75 |
| Average Market Value | 80,924.00 |
JFVAX : Stock Sector Breakout - 05/13
JFVAX : Top Holdings - 05/13
| Name | Weight | Shares |
|---|---|---|
| LOWE S COS INC | 4.97 | 1,239,454 |
| JPMORGAN CHASE + CO | 4.48 | 867,139 |
| BANK OF AMERICA CORP | 3.85 | 3,332,590 |
| CARNIVAL CORP | 3.64 | 775,138 |
| QUALCOMM INC | 2.82 | 388,317 |
| GOLDMAN SACHS GROUP INC | 3.38 | 222,698 |
| AVERY DENNISON CORP | 3.23 | 806,575 |
| MERCK + CO. INC. | 3.01 | 532,666 |
| WELLS FARGO + CO | 3.47 | 832,567 |